Vorotx
San Diego, US · 1 known investors
Voro Therapeutics develops tumor-activated biologics, specifically an antibody-based platform called PrimeBody™, designed to treat cancers including colorectal, gastric, prostate, and lung cancers while minimizing systemic toxicity. The company leverages masking technology and conditionally activated linkers to enable systemic delivery with tumor-specific activation.
Investors · 1
Competitors · 6
by search overlap
Fore7 shared keywordsFore Biotherapeutics is a clinical-stage oncology company developing targeted cancer therapies, including its lead plixorafenib program. It runs clinical trials such as the Forte Trial and offers expanded access programs for patients.
Valora Therapeutics4 shared keywordsValora Therapeutics is a biotech company developing antibody-lectin chimera (AbLec) therapeutics that target cell-surface glycans for immuno-oncology and immunotherapy applications. Its work builds on glycobiology and bioorthogonal chemistry research.
Zipdrug4 shared keywordsZipdrug is a prescription delivery and pharmacy benefit platform, acquired by Anthem's PBM IngenioRx in 2020.
Fortress Biotech4 shared keywordsFortress Biotech is a biopharmaceutical company that develops and commercializes pharmaceutical products, maintaining a pipeline of both revenue-generating commercial-stage products and development-stage drug candidates. It advances its products through partnerships within the pharmaceutical industry.
Robinhood4 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Forbion4 shared keywordsForbion is a global venture capital firm that invests in biotech innovations and sustainable solutions focused on human and planetary health. It integrates ESG principles into its investments, targeting patient impact, societal benefits, and sustainability.
Companies competing with Vorotx for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Vorotx do?
- Voro Therapeutics develops tumor-activated biologics, specifically an antibody-based platform called PrimeBody™, designed to treat cancers including colorectal, gastric, prostate, and lung cancers while minimizing systemic toxicity. The company leverages masking technology and conditionally activated linkers to enable systemic delivery with tumor-specific activation.
- Who are Vorotx's investors?
- Vorotx's investors include 82VS.
- Where is Vorotx headquartered?
- Vorotx is headquartered in San Diego, US.